Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Non Operating Income (2016 - 2025)

Angiodynamics (ANGO) has disclosed Non Operating Income for 16 consecutive years, with -$234000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 60.61% year-over-year to -$234000.0, compared with a TTM value of $5.7 million through Nov 2025, up 829.86%, and an annual FY2025 reading of $5.9 million, up 824.85% over the prior year.
  • Non Operating Income was -$234000.0 for Q4 2025 at Angiodynamics, down from -$178000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $5.4 million in Q1 2025 and bottomed at -$2.8 million in Q2 2023.
  • Average Non Operating Income over 5 years is -$61000.0, with a median of -$340000.0 recorded in 2021.
  • The sharpest move saw Non Operating Income tumbled 1756.25% in 2024, then surged 2381.51% in 2025.
  • Year by year, Non Operating Income stood at -$340000.0 in 2021, then tumbled by 175.29% to -$936000.0 in 2022, then surged by 96.58% to -$32000.0 in 2023, then crashed by 1756.25% to -$594000.0 in 2024, then soared by 60.61% to -$234000.0 in 2025.
  • Business Quant data shows Non Operating Income for ANGO at -$234000.0 in Q4 2025, -$178000.0 in Q3 2025, and $653000.0 in Q2 2025.